Next Article in Journal
In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells
Next Article in Special Issue
Cellular and Molecular Preconditions for Retinal Pigment Epithelium (RPE) Natural Reprogramming during Retinal Regeneration in Urodela
Previous Article in Journal
Synthesis and Preliminary Biological Evaluations of Fluorescent or 149Promethium Labeled Trastuzumab-Polyethylenimine
Previous Article in Special Issue
Cryopreserved Mesenchymal Stem Cells Stimulate Regeneration in an Intervertebral Disc
Article Menu

Export Article

Open AccessFeature PaperReview
Biomedicines 2016, 4(1), 2;

Stem Cell Therapies for Treatment of Liver Disease

William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN 55905, USA
Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
Author to whom correspondence should be addressed.
Academic Editor: Wenbin Deng
Received: 25 November 2015 / Revised: 30 December 2015 / Accepted: 31 December 2015 / Published: 6 January 2016
Full-Text   |   PDF [1185 KB, uploaded 6 January 2016]   |  


Cell therapy is an emerging form of treatment for several liver diseases, but is limited by the availability of donor livers. Stem cells hold promise as an alternative to the use of primary hepatocytes. We performed an exhaustive review of the literature, with a focus on the latest studies involving the use of stem cells for the treatment of liver disease. Stem cells can be harvested from a number of sources, or can be generated from somatic cells to create induced pluripotent stem cells (iPSCs). Different cell lines have been used experimentally to support liver function and treat inherited metabolic disorders, acute liver failure, cirrhosis, liver cancer, and small-for-size liver transplantations. Cell-based therapeutics may involve gene therapy, cell transplantation, bioartificial liver devices, or bioengineered organs. Research in this field is still very active. Stem cell therapy may, in the future, be used as a bridge to either liver transplantation or endogenous liver regeneration, but efficient differentiation and production protocols must be developed and safety must be demonstrated before it can be applied to clinical practice. View Full-Text
Keywords: stem cell; liver disease; induced pluripotent stem cells; gene correction; cell transplant; bioartificial liver; regenerative medicine; cell therapy stem cell; liver disease; induced pluripotent stem cells; gene correction; cell transplant; bioartificial liver; regenerative medicine; cell therapy

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Nicolas, C.; Wang, Y.; Luebke-Wheeler, J.; Nyberg, S.L. Stem Cell Therapies for Treatment of Liver Disease. Biomedicines 2016, 4, 2.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top